Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;179(4):625-641.
doi: 10.1111/bph.15677.

The role of glucagon-like peptide 1 (GLP-1) in addictive disorders

Mette Kruse Klausen  1 , Morgane Thomsen  2 , Gitta Wortwein  2   3 , Anders Fink-Jensen  1   2
Affiliations
Review

The role of glucagon-like peptide 1 (GLP-1) in addictive disorders

Mette Kruse Klausen et al. Br J Pharmacol. 2022 Feb.

Abstract

Drug, alcohol and tobacco use disorders are a global burden affecting millions of people. Despite decades of research, treatment options are sparse or missing, and relapse rates are high. Glucagon-like peptide 1 (GLP-1) is released in the small intestine, promotes blood glucose homeostasis, slows gastric emptying and reduces appetite. GLP-1 receptor agonists approved for treating Type 2 diabetes mellitus and obesity have received attention as a potential anti-addiction treatment. Studies in rodents and non-human primates have demonstrated a reduction in intake of alcohol and drugs of abuse, and clinical trials have been initiated to investigate whether the preclinical findings can be translated to patients. This review will give an overview of current findings and discuss the possible mechanisms of action. We suggest that effects of GLP-1 in alcohol and substance use disorders is mediated centrally, at least partly through dopamine signalling, but precise mechanisms are still to be uncovered. LINKED ARTICLES: This article is part of a themed issue on GLP1 receptor ligands (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.4/issuetoc.

Keywords: GLP-1; addiction; alcohol; alcohol use disorder; amphetamine; cocaine; dopamine; glucagon-like peptide-1; nicotine; opioids; substance use disorder; tobacco.

PubMed Disclaimer

Conflict of interest statement

A.F.‐J. has received an unrestricted research grant from Novo Nordisk A/S to investigate the effects of GLP‐1 receptor stimulation on metabolic disturbances and weight gain in antipsychotic‐treated patients with schizophrenia. There is no other possible conflicts of interest, for the remaining authors.

Figures

FIGURE 1
FIGURE 1
Effects of glucagon‐like peptide 1 (GLP‐1) receptor stimulation on alcohol reward‐related behaviours in preclinical models. CPP, conditioned place preference; DHipp, dorsal hippocampus; ex‐4, exenatide; ex‐9, exendin 9–39; LDTg, laterodorsal tegmental nucleus; LH, lateral hypothalamus; NAc, nucleus accumbens; NAcs, nucleus accumbens shell; NTS, nucleus tractus solitarius; VTA, ventral tegmental area
FIGURE 2
FIGURE 2
Effects of glucagon‐like peptide 1 (GLP‐1) receptor stimulation in various substance reward‐related behaviours in preclinical models. CPP, conditioned place preference; LS, lateral septum; NAc, nucleus accumbens; NTS, nucleus tractus solitarius; VTA, ventral tegmental area
See this image and copyright information in PMC

References

    1. Abd El Aziz, M. , Cahyadi, O. , Meier, J. J. , Schmidt, W. E. , & Nauck, M. A. (2020). Incretin‐based glucose‐lowering medications and the risk of acute pancreatitis and malignancies: A meta‐analysis based on cardiovascular outcomes trials. Diabetes, Obesity and Metabolism, 22(4), 699–704. 10.1111/dom.13924 - DOI - PubMed
    1. Abraham, K. A. , Kearney, M. L. , Reynolds, L. J. , & Thyfault, J. P. (2016). Red wine enhances glucose‐dependent insulinotropic peptide (GIP) and insulin responses in type 2 diabetes during an oral glucose tolerance test. Diabetology International, 7(2), 173–180. 10.1007/s13340-015-0234-y - DOI - PMC - PubMed
    1. Abtahi, S. , Howell, E. , & Currie, P. J. (2018). Accumbal ghrelin and glucagon‐like peptide 1 signaling in alcohol reward in female rats. Neuroreport, 29(12), 1046–1053. 10.1097/WNR.0000000000001071 - DOI - PubMed
    1. Alexander, S. P. H. , Christopoulos, A. , Davenport, A. P. , Kelly, E. , Mathie, A. , Peters, J. A. , Veale, E. L. , Armstrong, J. F. , Faccenda, E. , Harding, S. D. , Pawson, A. J. , Sharman, J. L. , Southan, C. , Davies, J. A. , & CGTP Collaborators . (2019). The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors. British Journal of Pharmacology, 176(S1), S21–S141. 10.1111/bph.14748 - DOI - PMC - PubMed
    1. Alexander, S. P. H. , Fabbro, D. , Kelly, E. , Mathie, A. , Peters, J. A. , Veale, E. L. , Armstrong, J. F. , Faccenda, E. , Harding, S. D. , Pawson, A. J. , Sharman, J. L. , Southan, C. , Davies, J. A. , & CGTP Collaborators . (2019). The Concise Guide to PHARMACOLOGY 2019/20: Enzymes. British Journal of Pharmacology, 176(S1), S297–S396. 10.1111/bph.14752 - DOI - PMC - PubMed

Publication types

Substances